STADA Arzneimittel AG — M&A Activity 2006

Sep 8, 2006

News Details

Corporate | 8 September 2006 15:41

STADA: After squeeze-out procedure STADA now holds 100% of Hemofarm shares

Corporate news transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— After completing a so-called squeeze-out procedure today, September 8, 2006, STADA Arzneimittel AG now holds 100% of the shares in Hemofarm a.d., Vrsac, Serbia. After the public takeover offer of July 14, 2006, STADA acquired 97.9% of the Hemofarm shares on August 14, 2006, thereby maintaining the possibility of a squeeze-out under Serbian law. STADA then initiated the relevant procedure on August 25, 2006 and, with the acquisition of the remaining Hemofarm shares, successfully completed it today. The acquisition of the shares by means of the squeeze-out procedure was carried out at a price of CSD 12,345 (currently EUR 149.46) per Hemofarm share and thus at the same price as offered in the scope of the public takeover offer. STADA thereby pays a total of approx. EUR 493.9 million for the acquisition of 100% of the Hemofarm’s shares. Additional Information: STADA Arzneimittel AG / Corporate Communications / Stadastrasse 2–18 / 61118 Bad Vilbel / Germany Phone: +49(0) 6101 603-113 / Fax: +49(0) 6101 603-506 / E-mail: communications@stada.de Or visit our website at www.stada.com (c)DGAP 08.09.2006 ————————————————————————— Language: English Issuer: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Deutschland Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de WWW: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Amtlicher Markt in Frankfurt (Prime Standard), Düsseldorf; Freiverkehr in Berlin-Bremen, Hannover, Hamburg, München, Stuttgart End of News DGAP News-Service —————————————————————————